The goal of this global independent network of researchers, professionals, medical doctors, patients and people interested in health is the production, updating and dissemination of high-quality Cochrane Reviews on the effects of interventions for patients with haematological malignancies. 

Cochrane Haematology was formed in 2000 by Prof. Andreas Engert and since January 2014, Prof. Dr. Nicole Skoetz is leading the group as co-ordinating editor. The Cochrane Haematology editorial base is situated at the Institute of Public Health of the University of Cologne, Germany. Besides of the team in Cologne, the Cochrane Haematology has an international network of editors worldwide, such as from Australia, Brasil, Germany, Denmark, Great Britain, Switzerland, and the United States who work together for improving quality of the Cochrane Reviews. In cooperation with other authors and patients from more than 20 other countries they build an active network for healt-care information.

The main area of focus are adult patients with haematological malignancies, such as leukaemias and lymphomas, but also non-oncological haematological diseases such as aplastic anaemia. We also focus on Cochrane Reviews about supportive care, stem cell transplantation and haematological growth factors.

The main roles are

• the development and publication of Cochrane Reviews within the main research area in the Cochrane Library
• the development of a register of randomised controlled clinical trials
• the knowledge transfer to medical doctors, patients, professionals and interested people

The CHMG follows the rules of Cochrane.